Gyan Barik on Wellumio’s IFAIR Perfusion Technology US Patent Gain
Gyan Barik, Executive Director at Wellumio, reposted from Wellumio on LinkedIn:
”Wellumio is proud to announce the granting of US Patent 12,495,983 B2 by the United States Patent Office for our innovative IFAIR perfusion technology.
This advancement equips clinicians with critical insights for stroke care, such as identifying salvageable brain tissue and guiding urgent treatment decisions.
We extend our deepest gratitude to our IP team for this achievement, marking a strong close to the year.”
Quoting Wellumio‘s post:
”US patent granted!
Thrilled to share the U.S. Patent Office granted US 12,495,983 B2 for our IFAIR perfusion technology.
IFAIR is an ASL-style tagging technique adapted for inhomogeneous magnetic fields.
In plain English, we measure brain blood flow without contrast agents or conventional MRI hardware.
IFAIR is the first ASL-like approach built for Pulsed Gradient-Free Mapping, enabling real-time, repeatable perfusion on a 0.1T device.
With IFAIR, Axana becomes the only portable scanner to deliver both diffusion and contrast-free perfusion at the bedside.
Pairing perfusion with diffusion at the bedside helps doctors answer urgent questions in stroke care, like ‘Is there still brain tissue that can be saved?’ and ‘How quickly should we move the patient for treatment?’
Huge thanks to our IP team. Great way to wrap up the year!”

Stay updated with Hemostasis Today.
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes
-
Oct 16, 2026, 09:50Mona Alfaraj: Distinguishing HCL from SMZL in Bone Marrow